Suppr超能文献

分子诊断对旅行者皮肤利什曼病管理的贡献。

Contribution of molecular diagnosis to the management of cutaneous leishmaniasis in travellers.

机构信息

Service de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; INSERM, U1043, Toulouse, France; CNRS, U5282, Toulouse, France; Université de Toulouse, UPS, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse, France.

出版信息

Clin Microbiol Infect. 2014 Aug;20(8):O528-30. doi: 10.1111/1469-0691.12487. Epub 2014 Jan 8.

Abstract

Cutaneous leishmaniasis is one of the most frequent skin diseases occurring after travelling in endemic areas. Optimal management requires identification of the species of Leishmania involved. In this study we aimed to evaluate the use of molecular diagnosis as routine, in comparison with direct examination and culture. Thirty positive diagnoses were carried out between 2007 and 2013. Classical PCR enabled 11 positive cases to be identified that were found to be negative by conventional methods. Sequencing led to the identification of eight different species. Routine use of PCR and sequencing appears very efficient in the management of cutaneous leishmaniasis.

摘要

皮肤利什曼病是旅行到流行地区后最常见的皮肤疾病之一。最佳治疗需要鉴定涉及的利什曼原虫种类。在本研究中,我们旨在评估与直接检查和培养相比,分子诊断作为常规的应用。在 2007 年至 2013 年间进行了 30 例阳性诊断。经典 PCR 使 11 例用传统方法被鉴定为阴性的病例得到确认。测序鉴定了 8 种不同的物种。常规使用 PCR 和测序在皮肤利什曼病的管理中非常有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验